After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
MIRM belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Mirum Pharmaceuticals Inc is $1.93B. A total of 0.52 million shares were traded on the day, compared to an average of 529.17K shares.
In the most recent transaction, Howe Jolanda sold 2,415 shares of MIRM for 44.45 per share on Mar 18 ’25. After the transaction, the SVP, GLOBAL CONTROLLER now owns 2,426 company shares. In a previous transaction on Mar 17 ’25, Howe Jolanda sold 57,606 shares at 44.35 per share. MIRM shares that SVP, GLOBAL CONTROLLER owns now total 4,841.
Among the insiders who sold shares, Radovich Peter disposed of 7,879 shares on Mar 17 ’25 at a per-share price of $44.21. This resulted in the PRESIDENT AND COO holding 18,672 shares of MIRM after the transaction. In another insider transaction, Peetz Christopher sold 27,279 shares at $44.21 per share on Mar 17 ’25. Company shares held by the CHIEF EXECUTIVE OFFICER now total 138,641.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, MIRM has a high of $54.23 and a low of $23.14.
As of this writing, MIRM has an earnings estimate of -$0.27 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.08 per share and a lower estimate of -$0.44.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. MIRM’s latest balance sheet shows that the firm has $156.54M in Cash & Short Term Investments as of fiscal 2021. There were $2.61M in debt and $42.60M in liabilities at the time. Its Book Value Per Share was $4.67, while its Total Shareholder’s Equity was $120.21M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MIRM is Buy with a score of 5.00.
